Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

Figure 2

Comparison of mean predictions for relapse-free survival by Adjuvant! with actual outcomes. Predicted outcome for percentage relapse-free survival at 10 years for each patient, based on their baseline clinical and pathological factors, was determined with the online prognostic tool Adjuvant!. The means of these predicted outcomes (black bars) are shown compared with the actual outcomes determined by Kaplan–Meier analysis (white bars, ± SEM) for the complete 313-patient cohort in the test set and with respect to patients subgrouped by banded biomarker score for the eight immunohistochemical biomarkers assessed in this study.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us